Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica A Slavin

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
Annals of Internal Medicine|January 20, 2015
Combination antifungal therapy for invasive aspergillosis: a randomized trialKieren A Marr, Haran T Schlamm, Raoul Herbrecht, et al.
Ejhaem|February 23, 2023
Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapyThi H O Nguyen, Chhay Lim, Masa Lasica, et al.
Intensive Care Medicine|February 3, 2025
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units-the SAFE-ICU studyJason A Roberts, Fekade B Sime, Jeffrey Lipman, et al.
The Lancet. Infectious Diseases|September 8, 2023
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patientsBenjamin W Teh, Malgorzata Mikulska, Dina Averbuch, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 25, 2025
Management of COVID-19 in immunocompromised patients: an European Society of Clinical Microbiology and Infectious Diseases consensus documentMichele Bartoletti, Ozlem Azap, Aleksandra Barac, et al.
Frontiers in Cellular and Infection Microbiology|January 13, 2022
Multilocus Sequence Typing Reveals Extensive Genetic Diversity of the Emerging Fungal Pathogen <i>Scedosporium aurantiacum</i>Azian Harun, Alex Kan, Katharina Schwabenbauer, et al.
The Lancet Regional Health. Western Pacific|November 18, 2024
Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodesGabrielle M Haeusler, S Ghazaleh Dashti, Fiona James, et al.
Open Forum Infectious Diseases|November 29, 2023
Evolution of Humoral and Cellular Immunity Post-Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-CilgavimabVictoria G Hall, Thi H O Nguyen, Lilith F Allen, et al.
The Lancet Regional Health. Western Pacific|September 13, 2023
Invasive aspergillosis in adult patients in Australia and New Zealand: 2017-2020Shio Yen Tio, Sharon C-A Chen, Kate Hamilton, et al.
The Medical Journal of Australia|May 14, 2020
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidanceRobert Weinkove, Zoe K McQuilten, Jonathan Adler, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Annals of Internal Medicine|January 20, 2015
Combination antifungal therapy for invasive aspergillosis: a randomized trialKieren A Marr, Haran T Schlamm, Raoul Herbrecht, et al.
Ejhaem|February 23, 2023
Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapyThi H O Nguyen, Chhay Lim, Masa Lasica, et al.
Intensive Care Medicine|February 3, 2025
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units-the SAFE-ICU studyJason A Roberts, Fekade B Sime, Jeffrey Lipman, et al.
The Lancet. Infectious Diseases|September 8, 2023
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patientsBenjamin W Teh, Malgorzata Mikulska, Dina Averbuch, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 25, 2025
Management of COVID-19 in immunocompromised patients: an European Society of Clinical Microbiology and Infectious Diseases consensus documentMichele Bartoletti, Ozlem Azap, Aleksandra Barac, et al.
Frontiers in Cellular and Infection Microbiology|January 13, 2022
Multilocus Sequence Typing Reveals Extensive Genetic Diversity of the Emerging Fungal Pathogen <i>Scedosporium aurantiacum</i>Azian Harun, Alex Kan, Katharina Schwabenbauer, et al.
The Lancet Regional Health. Western Pacific|November 18, 2024
Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodesGabrielle M Haeusler, S Ghazaleh Dashti, Fiona James, et al.
Open Forum Infectious Diseases|November 29, 2023
Evolution of Humoral and Cellular Immunity Post-Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-CilgavimabVictoria G Hall, Thi H O Nguyen, Lilith F Allen, et al.
The Lancet Regional Health. Western Pacific|September 13, 2023
Invasive aspergillosis in adult patients in Australia and New Zealand: 2017-2020Shio Yen Tio, Sharon C-A Chen, Kate Hamilton, et al.
The Medical Journal of Australia|May 14, 2020
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidanceRobert Weinkove, Zoe K McQuilten, Jonathan Adler, et al.
Pageof 23